Cabaletta Bio Inc (NASDAQ:CABA) price closed lower on current market day and dropping -0.84% below its previous close.
A look at the daily price movement shows that the last close reads $2.37. Taking into account the 52-week price action we note that the stock hit a 52-week high of $13.50 and 52-week low of $0.99. The stock added 97.48% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned CABA a recommendation rating as follows: 0 rate it as a Hold; 5 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Cabaletta Bio Inc (CABA) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that CABA’s price is at present 21.12% off the SMA20 and 56.44% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 69.98, with weekly volatility standing at 7.75%. The indicator jumps to 8.87% when calculated based on the past 30 days. Cabaletta Bio Inc (NASDAQ:CABA)’s beta value is holding at 2.80, while the average true range (ATR) indicator is currently reading 0.20. Considering analysts have assigned the stock a price target range of $3-$32 as the low and high respectively, we find the trailing 12-month average consensus price target to be $14. Based on this estimate, we see that current price is roughly -27.66% off the estimated low and -1261.7% off the forecast high. Investors will no doubt be excited to see the share price fall to $14, which is the median consensus price, and at that level CABA would be -495.74% from current price.
Current records show that the company has 50.74M in outstanding shares. The insiders’ percentage holdings are 9.03% of outstanding shares while the percentage share held by institutions stands at 67.14%. But the 3.52% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
